Aetna offers a broad range of traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans. Their customers include employer groups, individuals, college students, part-time and hourly workers, health plans, governmental units, government-sponsored plans, labor groups and expatriates. To learn more visit www.aetna.com.
Janssen Healthcare Innovation (JHI) is a newly established team within the Janssen Research & Development, LLC. JHI is expanding the company’s offerings of healthcare services and solutions by acquiring companies and programs, and establishing partnerships and collaborations both internally and externally. Their goal is to empower healthcare consumers and modernize healthcare delivery.
JHI is entrepreneurial in their pursuit of new and unique business models. Currently, JHI has commercial trials (commercial trials are learning pilot programs where data is gathered to assess scalability for future applications) running in areas such as personal genomics, virtual medicine and mobile health. Their portfolio of projects is designed to identify technologies and platforms that help consumers to better understand their own health, manage health information, make healthy lifestyle choices, better adhere to treatment regimens and improve their overall healthcare experience.
JHI is leveraging the deep understanding of the Janssen Family of Companies consumer’s needs, as well as its global consumer product, pharmaceutical, biotechnology and medical device development infrastructure to lead the transformation of the healthcare industry. To learn more visit www.janssenhealthcareinnovation.com.
Milestone Venture Partners is an early stage venture capital fund with $90 million under management. Milestone concentrates on companies that solve business problems and address consumer needs through the innovative application of information technology. Milestone invests approximately 50% of its capital in Digital Health businesses which provide information services to hospitals, physicians, pharmaceutical firms, health plans and consumers. To learn more visit www.milestonevp.com.
NEW LEAF VENTURE PARTNERS is a leading healthcare technology investor, managing approximately $1 billion in funds, and investments in 45 companies. They focus on 3 sectors: biopharmaceuticals, medical devices, and diagnostic/infrastructure technologies. Their goal is to build strong companies by supporting exceptional teams in the development of clinically important and commercially attractive products.
Across all sectors and stages, their investment decisions are primarily driven by a fundamental assessment of the risks in the underlying development programs (i.e., technical, clinical, regulatory, and commercial risks). Before making an investment, they work with the management teams to identify key milestones that must be met to reach points of meaningful value inflection, and they ensure that adequate resources are provided for the company to achieve those milestones.
The NLV investment team has deep operating experience and medical and technical expertise which are integral to their active investment approach. This allows them to work closely with founders, management, and co-investors to identify and execute on a capital efficient and optimal path to value creation and exit. This focused and fundamentals driven investment approach generates attractive returns for their investors.
NLV Partners has offices in New York and Menlo Park, California. They are currently making new investments through New Leaf Ventures II, a $450 million fund, which started its investing cycle in mid-2008. To learn more visit www.nlvpartners.com.
Partnership Fund for New York City is a private fund with a civic mission. The fund was the vision of Henry R. Kravis, founding partner of Kohlberg Kravis Roberts & Co., who serves as its Founding Chairman. His goal was to mobilize the city’s financial and business leaders to help build a stronger and more diversified local economy. To that end, the Fund has built a network of top experts from the investment and corporate communities who help identify and support New York City’s most promising entrepreneurs in both the for-profit and not-for-profit sectors.
The Fund was established in late 1996, under the auspices of the nonprofit The Partnership for New York City. It was initially capitalized by contributions of $1 million each from sixty-seven individual and corporate investors, who invested for the good of the city and without expectation of financial returns. This is an evergreen fund, in which realized gains are reinvested in other worthwhile projects.
The Fund has raised in excess of $110 million. Its investments typically range in size from $1 million to $5 million. The Fund provides equity or debt, structured to meet the needs of the project. It will invest at any stage of business development, but is seeking to exit in about five years. To date, the Fund has invested in more than 100 projects. To learn more visit fund.pfnyc.org.
Quaker Partners Management, L.P. is an East Coast-focused healthcare investment firm. The funds that they manage pursue a traditional venture capital strategy, leading equity investments in healthcare companies at all stages of development. Their industry expertise includes pharmaceuticals, biotechnology, healthcare services, and medical technologies such as devices, tools and human diagnostics. Since its founding in 2002, Quaker has invested in dozens of innovative, high impact healthcare companies. Quaker manages over $700 million in committed capital, and is currently investing its second fund. To learn more visit www.quakerbio.com.
Safeguard Scientifics provides growth capital for entrepreneurial and innovative life sciences and technology companies. Safeguard targets life sciences companies in Molecular and Point-of-Care Diagnostics, Medical Devices, Regenerative Medicine and Specialty Pharmaceuticals, and technology companies in Internet / New Media, Financial Services IT and Healthcare IT with capital requirements of up to $25 million. Safeguard participates in expansion financings, corporate spin-outs, management buyouts, recapitalizations, industry consolidations and early-stage financings.
Safeguard has deployed capital in and provided operational expertise and support to hundreds of companies, entrepreneurs and management teams, successfully completing more than 100 M&A transactions and 20 IPOs. Safeguard’s prudent and innovative approach to identifying market leaders in key strategic sectors has spawned household names and industry leaders including Novell, QVC, Cambridge Technology Partners, Internet Capital Group, CompuCom Systems and Traffic.com. To learn more visit www.safeguard.com.
UnitedHealth Group is a leading health care company, serving more than 75 million people worldwide. Their family of companies touches nearly every aspect of health care, helping people live healthier lives.
They apply their capabilities broadly across healthcare in markets worldwide, providing healthcare management, consulting and specialty services globally. And they have the scale and resources necessary to take on some of the most important challenges in global health care.
As a leader in the health benefits and services industry, their six businesses — UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, OptumHealth, OptumInsight, and OptumRx — offer exceptional service, broad capabilities and enduring value in creating a modern health care system. Their products and services empower individuals, expand consumer choice and strengthen patient-provider relationships across the health care spectrum. To learn more visit www.unitedhealthgroup.com.